Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 901–1,000 of 1,002
Iwane, S., Nemoto, W., Miyamoto, T., Hayashi, T., Tanaka, M., Uchitani, K., Muranaka, T., Fujitani, M., Koizumi, Y., Hirata, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51572-z · Cited by 24
“DPN in T2DM patients was diagnosed by a physician at intervals of 2–12 weeks, according to the diagnostic criteria of diabetic neuropathies 22 and patient’s complaints.”
CASELLINI, C. M., Parson, H. K., Frizzi, K. E., Marquez, A., Smith, D. R., Guernsey, L. S., Nemmani, R., Tayarani, A., Jolivalt, C. G., Weaver, J. R., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02710-4 · Cited by 21
“Inclusion criteria were diagnosis of type 2 diabetes of > 2 years according to published guidelines [48] and confirmed diagnosis of diabetic peripheral neuropathy according to the Toronto Consensus guidelines [49].”
Self-citationTreatment of type 2 diabetes mellitus in the elderly – Special considerations
Gadó, K., Tabák, Á. G., Vingender, I., Domján, G., & Dörnyei, G. (2024) · Physiology International · doi:10.1556/2060.2024.00317 · Cited by 27
Reproducibility of methods used for the assessment of autonomous nervous system's function
Tannus, L. R. M., Sperandei, S., Montenegro, R. M., Carvalho, V. R., Pedrosa, H. C., Félix, M. T., Canani, L. H. S., Zucatti, A. T. N., de Oliveira, D. H. A., Rea, R. R., et al. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.05.444 · Cited by 22
O'Brien, T., & Karem, J. (2014) · Journal of the American Podiatric Medical Association · doi:10.7547/0003-0538-104.2.134 · Cited by 25
“It is known to affect most diabetic patients, and its progression is thought to be directly proportional to the duration and severity of the disease.(2,3) The importance of prompt diagnosis of DPN and implementation of preventive strategies designed to reduce complications leading to limb loss has been recognized as a…”
BackgroundAnkle-brachial index and diabetic neuropathy: study of 225 patients
Chevtchouk, L., da Silva, M. H. S., & Nascimento, O. J. M. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170084 · Cited by 21
The Application of SUDOSCAN for Screening Diabetic Peripheral Neuropathy in Chinese Population
Jin, J., Wang, W., Gu, T., Chen, W., Lü, J., Bi, Y., & Zhu, D. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-116673 · Cited by 22
“One of the most common long-term complication of diabetes include diabetic peripheral neuropathy (DPN) and this consists of two major subgroups, diabetic sensorimotor polyneuropathy (DSPN) and cardiovascular autonomic neuropathy (CAN)[2].”
BackgroundSeferović, J. P., Pfeffer, M. A., Claggett, B. L., Desai, A. S., de Zeeuw, D., Haffner, S. M., McMurray, J. J. V., Parving, H., Solomon, S. D., & Chaturvedi, N. (2017) · Diabetologia · doi:10.1007/s00125-017-4485-y · Cited by 22
Arterial Stiffness Is Associated with Peripheral Sensory Neuropathy in Diabetes Patients in Ghana
Yeboah, K., Agyekum, J. A., Owusu‐Mensah, R. N. A., Affrim, P. K., Adu-Gyamfi, L., Doughan, R. O., & Adjei, A. B. (2018) · Journal of Diabetes Research · doi:10.1155/2018/2320737 · Cited by 25
“Another notable caution about VPT is that it is used to assess probable neuropathy and nerve conduction studies are required for confirmation [35].”
BackgroundInvolvement of P2Y12 receptor of stellate ganglion in diabetic cardiovascular autonomic neuropathy
Guo, J., Sheng, X., Yu, D., Xu, Y., Zhang, Y., Ji, H., Wang, J., Xu, Z., Che, H., Li, G., et al. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9616-5 · Cited by 21
Lin, J., He, Y., Zhu, N., & Peng, B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2642-4 · Cited by 22
Bencsik, P., Kiss, K., Ágg, B., Baán, J. A., Ágoston, G., Varga, A., Gömöri, K., Mendler, L., Faragó, N., Zvara, Á., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040991 · Cited by 21
“Diabetic sensory neuropathy [4], see [3] for a review, affects the heart due to its rich sensory innervations [1,5].”
BackgroundIsmail, C. A. N., Suppıan, R., Aziz, C. B. A., & Long, I. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00411-4 · Cited by 22
Tummanapalli, S. S., Issar, T., Kwai, N. C. G., Pisarcikova, J., Poynten, A. M., Krishnan, A. V., Willcox, M. D. P., & Markoulli, M. P. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1705984 · Cited by 21
“DPN was defined using the Toronto consensus criteria.(1) Neuropathy severity was graded to yield a Total Neuropathy Score (TNS).”
BackgroundMethodZiegler, D., Landgraf, R., Lobmann, R., Reiners, K., Kristian, R. E. T. T., Schnell, O., & Strom, A. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13267 · Cited by 21
Wu, H., Yao, J.-Y., Qi, J.-Y., Xie, H., Sang, A., & Jiang, K. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.01.20 · Cited by 23
Liu, M., Gao, Y., Chen, D., Lin, S., Wang, C., Chen, L., & Ran, X. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13515 · Cited by 24
Peripheral Polyneuropathy and Cognitive Impairment in Type II Diabetes Mellitus
Elsharkawy, R. E., Azim, G. S. A., Osman, M. A., Maghraby, H. M., Mohamed, R. A. E., Abdelsalam, E. M., Ebrahem, E. E., & Seliem, N. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s284308 · Cited by 22
“Chronic hyperglycemia can cause nerve affection by activation of the polyol pathway, reactive oxygen species (ROS) and through the accumulation of advanced glycation end products (AGE) that activate inflammatory cascades.(15) In this study we found that in both diabetic patients group (with painless and painful neurop…”
BackgroundBjerg, L., Nicolaisen, S. K., Christensen, D. H., Nielsen, J. S., Andersen, S. T., Jørgensen, M. E., Jensen, T. S., Sandbæk, A., Andersen, H., Beck‐Nielsen, H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0010 · Cited by 23
Chen, J. L., Hesseltine, A. W., Nashi, S. E., Sills, S. M., McJunkin, T. L., Patil, S., Bharara, M., Caraway, D. L., & Brooks, E. S. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211060316 · Cited by 23
Advances in screening, early diagnosis, and accurate staging of diabetic neuropathy
Carmichael, J., Fadavi, H., Ishibashi, F., Shore, A. C., & Tavakoli, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820669-0.00018-9 · Cited by 22
Fibromyalgia syndrome—A laser‐evoked potentials study unsupportive of small nerve fibre involvement
Assche, D. C. F. V., Plaghki, L., Masquelier, É., & Hatem, S. M. (2019) · European Journal of Pain · doi:10.1002/ejp.1501 · Cited by 23
“Definite diagnosis of diabetic SFN needs (1) the presence of length‐dependent neuropathic symptoms, (2) normal nerve conduction studies and (3) abnormal QST or abnormal IENF density in skin punch biopsies (Tesfaye et al., 2010).”
BackgroundGuo, X., Yu, Y., Zhang, Y., Sun, L., Li, Y., Song, B., Li, H., Baba, M., Wasaki, Y., Kikumori, K., et al. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00617-2 · Cited by 20
“If the results of a nerve conduction study were normal, patients could meet the “probable” criterion if they met at least two of the following criteria: (1) neuropathic symptoms, (2) decreased distal sensation, and (3) unequivocally decreased or absent ankle reflexes [21].”
Fan, S., Qiu, Y., Liu, J., Zhu, T., Wang, C., Liu, D., Yan, L., & Ren, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16242 · Cited by 21
Small-Fiber Neuropathy: An Etiology-Oriented Review
Furia, A., Liguori, R., & Donadio, V. (2025) · Brain Sciences · doi:10.3390/brainsci15020158 · Cited by 25
“Currently, a diagnosis of SFN can be made based on two different sets of criteria [2,11], as highlighted in Table 2.”
Sun, M., Sun, X., Fei, W., & Liu, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1614657 · Cited by 28
“DPN was diagnosed based on the presence of neuropathy-related clinical signs or symptoms and abnormal electromyography results, following the Toronto Expert Consensus (14).”
McCormick, K. G., Scorletti, E., Bhatia, L. S., Calder, P. C., Griffin, M. J., Clough, G. F., & Byrne, C. D. (2015) · Diabetologia · doi:10.1007/s00125-015-3628-2 · Cited by 20
“Peripheral neuropathy is associated with cardiovascular disease [38], and increased vibration thresholds have been shown to be a risk factor for mortality with diabetes [39].”
BackgroundPanagoulias, G., Eleftheriadou, I., Παπάνας, Ν., Manes, C., Kamenov, Z. A., Tešić, D., Bousboulas, S., Tentolouris, A., Jude, E. B., & Tentolouris, N. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00625 · Cited by 23
“Similar reasons preclude the use of QSART, the thermoregulatory sweat test, and the quantitative direct and indirect reflex test (QDIRT) that assess sudomotor dysfunction for the prediction of DFU (14).”
BackgroundResultWegeberg, A., Lunde, E. D., Riahi, S., Ejskjær, N., Drewes, A. M., Brock, B., Pop‐Busui, R., & Brock, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108517 · Cited by 21
Chuar, P. F., Ng, Y. T., Phang, S. C. W., Koay, Y. Y., Ho, J.-I., Ho, L. S., Botross, N. P., Ahmad, B., & Kadir, K. A. (2021) · Nutrients · doi:10.3390/nu13113770 · Cited by 24
Serhiyenko, V. A., Serhiyenko, L. M., Sehin, V. B., & Serhiyenko, A. A. (2021) · Endocrine Regulations · doi:10.2478/enr-2021-0024 · Cited by 22
Diabetic Foot Ulcers and Cardiac Autonomic Neuropathy
Basra, R., Παπάνας, Ν., Farrow, F., Karalliedde, J. J., & Vas, P. R. J. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.12.002 · Cited by 21
Dunker, Ø., Grotle, M., Kvaløy, M. B., Uglem, M., Løseth, S., Hjelland, I. E., Kleggetveit, I. P., Allen, S. M., Vigeland, M. D., Killingmo, R. M., et al. (2022) · Pain · doi:10.1097/j.pain.0000000000002793 · Cited by 20
“[58], as these also fit general distal, symmetrical polyneuropathies.”
A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument
Haque, F., Reaz, M. B. I., Chowdhury, M. E. H., Shapiai, M. I., Malik, R. A., Alhatou, M. I., Kobashi, S., Ara, I., Ali, S. H. M., Bakar, A. A. A., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020264 · Cited by 25
“The American Diabetic Association (ADA) [1] and Toronto consensus statements [6] recommended that the diagnosis of DSPN should be based on an assessment of symptoms and signs and nerve conduction studies (NCS).”
BackgroundMethodSelf-citationAssociation of arterial stiffness and neuropathy in diabetes: a systematic review and meta-analysis
Beros, A. L., Sluyter, J., & Scragg, R. K. R. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003140 · Cited by 23
“Studies were judged to be of high quality ( ≥ 3 for cross-sectional studies or ≥ 5 for case-control or cohort studies) or low quality (<3 for cross-sectional studies or <5 for case-control or cohort studies).”
Osaka, T., Hamaguchi, M., & Fukui, M. (2023) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514231161885 · Cited by 23
Croosu, S. S., Gjela, M., Røikjer, J., Hansen, T. M., Mørch, C. D., Frøkjær, J. B., & Ejskjær, N. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.420 · Cited by 21
Zhang, X., Liang, Z., Zhou, Y., Wang, F., Wei, S., Tan, B., & Guo, Y. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00619 · Cited by 20
Neurologic Complications of Diabetes
Charnogursky, G. A., Emanuele, N., & Emanuele, M. A. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0457-5 · Cited by 22
MicroRNA transport in cardiovascular complication of diabetes
Caporali, A., Miscianinov, V., Saif, J., & Emanueli, C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.010 · Cited by 22
Araszkiewicz, A., Gandecka, A., Nowicki, M. O., Uruska, A. A., Malińska, A., Kowalska, K., Wierusz‐Wysocka, B., & Zozulińska‐Ziółkiewicz, D. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3649 · Cited by 20
Guzyk, M. M., Dyakun, K., Yanitska, L. V., Pryvrotska, I. B., Krynytska, І., Pishel, I., & Kuchmerovska, T. M. (2017) · Neurophysiology · doi:10.1007/s11062-017-9672-4 · Cited by 20
Retrospective analysis of ocular neuropathies in diabetic dogs following cataract surgery
Foote, B. C., Michau, T. M., Welihozkiy, A. T., & Stine, J. M. (2018) · Veterinary Ophthalmology · doi:10.1111/vop.12589 · Cited by 22
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy
Restivo, D. A., Casabona, A., Frittitta, L., Belfiore, A., Moli, R. L., Gullo, D., & Vigneri, R. (2018) · Annals of Neurology · doi:10.1002/ana.25340 · Cited by 21
Christensen, D. H., Knudsen, S. T., Nicolaisen, S. K., Andersen, H., Callaghan, B. C., Finnerup, N. B., Jensen, T. S., & Thomsen, R. W. (2019) · Clinical Epidemiology · doi:10.2147/clep.s197474 · Cited by 20
Cardinez, N., Lovblom, L. E., Orszag, A., Bril, V., Cherney, D. Z. I., & Perkins, B. A. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.06.002 · Cited by 20
Liu, Y., Dai, W., & Ye, S. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1691603 · Cited by 20
“DN is a common microvascular complication of diabetes and characterised by the presence of urine albumin excretion, diabetic glomerular lesions, and loss of glomerular filtration rate in diabetics (Verzola et al. 2007, Cheng 2005, Tesfaye et al. 2010).”
BackgroundFeasibility of Point Shear Wave Elastography for Evaluating Diabetic Peripheral Neuropathy
Wei, M., & Ye, X. (2019) · Journal of Ultrasound in Medicine · doi:10.1002/jum.15198 · Cited by 20
“The diagnosis of DPN depends on neuropathy symptoms, a physical examination of signs, and nerve conduction studies (NCSs).(4,5) In recent years, high-frequency ultrasound (US) has been considered a good complementary technique for the noninvasive assessment of DPN, as it can evaluate neuropathy by showing morphologic…”
BackgroundTear biomarkers and corneal sensitivity as an indicator of neuropathy in type 2 diabetes
Iyengar, M., Soto, L. F., Requena, D., Ruíz-Alejos, A., Huaylinos, Y., Velasquez, R., Bernabé‐Ortiz, A., & Gilman, R. H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108143 · Cited by 23
“Corneal nerve damage can act as the bridge between tear biomarkers and DPN findings (16), as IVCM findings have been correlated with early DPN as well as changes in tear biomarker concentrations (5, 9).”
BackgroundWegeberg, A., Brock, C., Ejskjær, N., Karmisholt, J., Jakobsen, P. E., Drewes, A. M., Brock, B., & Farmer, A. D. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13885 · Cited by 22
“Disease Duration (y) 20 (13-31) 31 (25-40) <.”
Hu, A., Koh, B. H. J., & Teo, M. R. (2020) · Diabetology International · doi:10.1007/s13340-020-00451-9 · Cited by 23
Reduced Thalamic Volume and Metabolites in Type 1 Diabetes with Polyneuropathy
Hansen, T. M., Frøkjær, J. B., Selvarajah, D., Muthulingam, J. A., Tesfaye, S. H., Juhl, A. H., Drewes, A. M., Jakobsen, P. E., Karmisholt, J., Brock, B., et al. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1347-2579 · Cited by 20
Self-citationZhang, Y., Fan, D., Zhang, Y., Zhang, S., Wang, H., Liu, Z., & Wang, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-94284-4 · Cited by 20
Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy
Okdahl, T., & Brock, C. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01397-1 · Cited by 21
“Taken together, in recent years, DPN-focused research has evolved from a glucocentric viewpoint to a broader understanding of the underlying pathophysiology secondary to multiple linked metabolic and inflammatory insults including oxidative stress, reduced levels of nerve growth factors, and structural vascular change…”
BackgroundStavniichuk, R., Obrosov, A. A., Drel, V. R., Nadler, J. L., Obrosova, I. G., & Yorek, M. A. (2013) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2013.33015 · Cited by 20
“OPEN ACCESS R. Stavniichuk et al. / Journal of Diabetes Mellitus 3 (2013) 101-110 107 the diabetic milieu [41-45] revealed that 12/15-lipoxygenase overexpression and activation is implicated in multiple biochemical changes including increased phosphorylation of ERK and p38 MAPK, Ras activation, cAMP response element-b…”
InfluentialGlycated albumin indicates peripheral diabetic neuropathy
Wang, N., Guo, C., Han, P., & Li, T. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0900-y · Cited by 20
Ji, H., Lu, Y., liu, G., Zhao, X., Xu, M., & Chen, M. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s467409 · Cited by 20
Ming, S., Lei, Z., & Jie, W. (2025) · Interdisciplinary Research in Medical Sciences Specialty · doi:10.51847/2at3p1kejs · Cited by 19
Zeng, Q., Dong, S.-Y., Ml, W., Wang, F., Li, J., & Xl, Z. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2015.126 · Cited by 19
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 22
Liu, Y., Yu, P., Jin, J., Chen, Y., Chen, C., Chen, Z., Huang, H., & Xu, L. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13507 · Cited by 21
Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy
Karahmet, E., Prnjavorac, B., Bego, T., Softič, A., Begić, L., Begić, E., Karahmet, E., Prnjavorac, L., & Prnjavorac, I. (2020) · Medicinski Glasnik · doi:10.17392/1279-21 · Cited by 20
Haque, F., Reaz, M. B. I., Chowdhury, M. E. H., Serkan Kiranyaz, B., Ali, S. H. M., Alhatou, M. I., Habib, R., Bakar, A. A. A., Arsad, N., & Srivastava, G. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/9690940 · Cited by 21
“NCS has been considered as the benchmark for the identification and stratification of DSPN [1, 14].”
BackgroundMethodRecent updates in the treatment of diabetic polyneuropathy
Fan, Q., & Smith, A. G. (2022) · Faculty Reviews · doi:10.12703/r/11-30 · Cited by 21
Liu, X., Chen, D., Fu, H., Liu, X., Zhang, Q.-M., Zhang, J., Ding, M., Wen, J., & Chang, B. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1128069 · Cited by 23
Endogenous Lebanese Plants Treating Diabetes and Related Complications
Raafat, K. M. (2013) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000112 · Cited by 19
Association of peripheral nesfatin-1 with early stage diabetic nephropathy
Irannejad, A., Ghajar, A., Afarideh, M., Khajeh, E., Noshad, S., Esteghamati, S., Afshari, K., Kahe, F., Ganji, M., Saadat, M., et al. (2016) · Pathophysiology · doi:10.1016/j.pathophys.2016.12.001 · Cited by 19
Shiomi, M., Takada, T., Tanaka, Y., Yajima, K., Isomoto, A., Sakamoto, M., & Otori, K. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12900 · Cited by 20
Costa, Y. M., Karlsson, P., Bonjardim, L. R., Conti, P. C. R., Tankişi, H., Jensen, T. S., Nyengaard, J. R., Svensson, P. J., & Baad‐Hansen, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37041-4 · Cited by 20
Galstyan, G. R., Starostina, E. G., Yakhno, N. N., Владимировна, Г. И., Churyukanov, M. V., Strokov, I. A., Tokmakova, A. Y., Kukushkin, M. L., Martynov, A. I., & Shestakova, M. V. (2019) · Diabetes Mellitus · doi:10.14341/dm9625 · Cited by 24
Muscle fatigability in patients with type 2 diabetes: relation with long‐term complications
Orlando, G., Sacchetti, M., D’Errico, V., Haxhi, J., Rapisarda, G., Pugliese, G., & Balducci, S. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3231 · Cited by 23
“The diagnosis of DPN was based on symptoms, signs, and neuro‐ electrophysiological abnormalities according to the Toronto Diabetic Neuropathy Expert Group.(21) Symptoms and signs of DPN were evaluated using the Michigan Neuropathy Screening Instrument including a 15‐item self‐administered questionnaire and a lower ext…”
MethodCorneal nerve fiber loss in diabetes with chronic kidney disease
Tummanapalli, S. S., Issar, T., Yan, A., Kwai, N. C. G., Poynten, A. M., Krishnan, A. V., Willcox, M. D. P., & Markoulli, M. P. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.11.010 · Cited by 22
Dutra, L. M. A., Moura, M. C., do Prado, F. A., Lima, G. D. O., Melo, M. C., Fernandez, R. N. M., & Novaes, M. R. C. G. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00534-2 · Cited by 23
Pinto, M. V., da Rosa, L. C. G. F., Pinto, L. F., Dantas, J. R., Salles, G. F., Zajdenverg, L., Rodacki, M., & Lima, M. A. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00594-4 · Cited by 21
Qian, Y., Zeng, Y., Lin, Q., Huang, H., Zhang, W., Yu, H., & Deng, B. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13535 · Cited by 19
Nádró, B., Lőrincz, H., Molnár, Á., Szentpéteri, A., Zöld, E., Seres, I., Páll, D., Paragh, G., Kempler, P., Harangi, M., et al. (2021) · Journal of International Medical Research · doi:10.1177/03000605211012213 · Cited by 19
“The pathological mechanisms of diabetic neuropathy are generally accepted to be multifactorial, although the exact cellular mechanisms are not yet fully understood.(1) The main components are likely to be the hyperglycemiainduced activation of alternative metabolic pathways (including increased polyol and hexosamine p…”
BackgroundSelf-citationWegeberg, A., Okdahl, T., Riahi, S., Ejskjær, N., Pociot, F., Størling, J., Brock, B., & Brock, C. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01437-w · Cited by 21
“In diabetes, this balance may be tilted by diabetic neuropathy, which can impact the body’s neuronal regulation both peripherally, centrally, and within the autonomic nervous system, leading to debilitating, body encompassing complications [3].”
BackgroundCroosu, S. S., Hansen, T. M., Brock, B., Drewes, A. M., Brock, C., & Frøkjær, J. B. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147882 · Cited by 22
“, 2019) From the Department of Endocrinology, Aalborg University Hospital, the study included 48 subjects with a verified diagnosis of T1DM for minimum two years (hemoglobin A1c (HbA1c) ≥ 7%) and confirmed DPN, based on the Toronto criteria.(Tesfaye et al., 2010).”
An overview of painful diabetic peripheral neuropathy: Diagnosis and treatment advancements
Hagedorn, J. M., Engle, A. M., George, T. K., Karri, J. V., Abdullah, N. M., Ovrom, E. A., Bocanegra‐Becerra, J. E., & D'Souza, R. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109928 · Cited by 23
Petropoulos, I. N., Javed, S., Azmi, S., Khan, A., Ponirakis, G., & Malik, R. A. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.06.002 · Cited by 22
Self-citationAnemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes
Chung, J. O., Park, S., Cho, D. H., Chung, D. J., & Chung, M. Y. (2017) · Medicine · doi:10.1097/md.0000000000006586 · Cited by 19
Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy
Xiong, Q., Lü, B., Ye, H., Liu, S., Zheng, H., Zhang, R., Qiao, X., Zhang, S., Liu, X., Li, Q., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.026 · Cited by 19
Sajic, M., Ida, K. K., Canning, R., Gregson, N. A., Duchen, M. R., & Smith, K. J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1094-8 · Cited by 20
Diabetische Neuropathie und diabetischer Fuß (Update 2019)
Lechleitner, M., Abrahamian, H., Francesconi, C., Kofler, M., Sturm, W., & Köhler, G. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1487-4 · Cited by 18
Lu, X., Xu, R., Dong, X., Bai, D., Ji, W., Chen, X., Chen, H., Hou, C., & Gao, J. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04432-0 · Cited by 20
“These structural deficits culminate in the characteristic clinical findings in DPN: neuropathic pain, sensory loss, and motor impairment [46].”
In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes
Kwai, N. C. G., Arnold, R., Poynten, A. M., Howells, J., Kiernan, M. C., Lin, C. S.-Y., & Krishnan, A. V. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.11.047 · Cited by 18
“There is no specific treatment for DPN aside from symptom management and glycaemic control (Tesfaye et al., 2010).”
Pemp, B., Palkovits, S., Howorka, K., Pumprla, J., Sacu, S., Garhöfer, G., Bayerle‐Eder, M., Schmetterer, L. F., & Schmidt-Erfurth, U. M. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13733 · Cited by 18
“Reduced heart rate variation is the earliest indicator of CAN and therefore one of the earliest signs of peripheral diabetic neuropathy (Ziegler 1994; Tesfaye et al. 2010).”
BackgroundDiabetic Cardiac Autonomic Neuropathy
Serhiyenko, V. A., & Serhiyenko, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_53 · Cited by 18
Choi, D., Kim, B., Jung, C., Kim, C., & Mok, J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0219 · Cited by 20
Knoerl, R., Mazzola, E., Mitchell, S. A., Hong, F., Salehi, E., McCleary, N. J., Ligibel, J. A., Reyes, K., & Berry, D. L. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00377-z · Cited by 18
Sabeti, F., Carle, C. F., Nolan, C. J., Jenkins, A. J., James, A. C., Baker, L., Coombes, C., Cheung, V., Chiou, M., & Maddess, T. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02382-2 · Cited by 18
Κender, Ζ., Groener, J. B., Jende, J. M. E., Kurz, F. T., Fleming, T. H., Sulaj, A., Schuh‐Hofer, S., Treede, R., Bendszus, M., Szendroedi, J., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15446 · Cited by 20
“Thus, the majority of questionnaires and neuropathy assessments in diabetes focus on symptoms of the lower limbs [8, 9].”
BackgroundFirouzabadi, M. D., Poopak, A., Sheikhy, A., Samimi, S., Nakhaei, P., Firouzabadi, F. D., Moosaie, F., Rabizadeh, S., Nakhjavani, M., & Esteghamati, A. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.11.011 · Cited by 20
He, Q., Zeng, Z., Zhao, M., Ruan, B., & Chen, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-40752-y · Cited by 20
Early diabetic eye damage: Comparing detection methods using diagnostic power
Rai, B. B., van Kleef, J., Sabeti, F., Vlieger, R., Suominen, H., & Maddess, T. (2023) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2023.09.002 · Cited by 20
Serum neurofilament light chain – A potential biomarker for polyneuropathy in type 2 diabetes?
Määttä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Sandbæk, A., Tankişi, H., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110988 · Cited by 21
Walle, M., Duseja, A., Whittier, D. E., Vilaça, T., Paggiosi, M., Eastell, R., Müller, R., & Collins, C. J. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjad014 · Cited by 18
Mizrak, H. I., Kufaishi, H., Hecquet, S. K., Hansen, T. W., Pop‐Busui, R., Rossing, P. R., Brock, B., & Hansen, C. S. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108761 · Cited by 18
Hansen, T. M., Croosu, S. S., Røikjer, J., Mørch, C. D., Ejskjær, N., & Frøkjær, J. B. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.06.017 · Cited by 18
Didangelos, T., Karlafti, E., Kotzakioulafi, E., Giannoulaki, P., Kontoninas, Z., Kontana, A., Evripidou, P., Savopoulos, C., Birkenfeld, A. L., & Kantartzis, K. (2024) · Nutrients · doi:10.3390/nu16183045 · Cited by 18
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.